Molecular Simulation–Driven Drug Repurposing for the Identification of Inhibitors Against Non-Structural Proteins of SARS-CoV-2
Molecular Simulation–Driven Drug Repurposing for the Identification of Inhibitors Against Non-Structural Proteins of SARS-CoV-2
A. Pathak,Bhumika Singh,D. Chaurasia,B. Jayaram
2021 · DOI: 10.1007/7653_2020_61
0 Citations
TLDR
This study identified computationally a few drugs showing good molecular interactions with known targets of SARS-CoV-2 and proposed 16 FDA-approved drug molecules as potential drug candidates for further experimental assessment.